Cancer Treatment Market Research Reports & Industry Analysis

Worldwide cancer affects more than 10 million people each year and the incidence of cancer is expected to increase by 2.4% annually to reach 14 million per year by 2020. Cancer is the second most common death in the industrialized world.

Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.

With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.

...Show More ...Show Less


Cancer Treatment Industry Research & Market Reports

  • Global & United Arab Emirates Cancer Therapeutics Market to 2031

    ... In the federal budget for 2022, 8.4% of the government’s approved public spending—totaling US$15.8 billion (AED 58.931 billion)—was allocated to the healthcare sector. The UAE government remains the primary financier of its healthcare system and ... Read More

  • Global & United Kingdom Cancer Therapeutics Market to 2031

    ... by 2040.The emergence of immune checkpoint inhibitors has significantly transformed cancer treatment, offering renewed hope to patients. The UK also hosts Cancer Research UK, the world’s largest independent cancer charity. Each year, the organization allocates ... Read More

  • Global & Ukraine Cancer Therapeutics Market to 2031

    ... according to the World Health Organization. This figure is expected to rise in the coming years due to an aging population and the increasing prevalence of unhealthy lifestyle habits. As a result, there is a ... Read More

  • Global & United States Cancer Therapeutics Market to 2031

    ... reach around 2 million. Colorectal cancer ranks as the third most commonly diagnosed cancer among both men and women in the U.S., according to the American Society of Clinical Oncology. In 2023, about 150,000 adults ... Read More

  • Global & Austria Cancer Therapeutics Market to 2031

    ... around 50,000 annual cases by 2030. By that same year, the total number of individuals living with cancer in the country is projected to reach 460,000—an increase of 15% compared to 2022. The most frequently ... Read More

  • Global & Brazil Cancer Therapeutics Market to 2031

    ... of the population. This number is projected to increase to nearly 50 million by 2030, representing 24% of the total population. With a steadily aging population, Brazil is witnessing a surge in cancer incidence, particularly ... Read More

  • Global & Germany Cancer Therapeutics Market to 2031

    ... Organization (WHO) indicates that in 2022, Germany registered approximately 630,000 new cancer cases and around 250,000 cancer-related deaths. This growing burden is driving a strong demand for more effective treatment options. Germany is also recognized ... Read More

  • Global & Qatar Cancer Therapeutics Market to 2031

    ... The increasing number of cancer diagnoses has led to greater emphasis on advanced treatment options, including immunotherapy and targeted therapies. Healthcare is a priority for Qatar’s government under its National Vision 2030, which aims to ... Read More

  • Global & Sweden Cancer Therapeutics Market to 2031

    ... role in developing cutting-edge immuno-oncology therapies targeting cancers such as lung and bladder cancer. The Swedish government has taken proactive steps to strengthen its oncology sector through comprehensive national strategies. One such initiative, the Cancer ... Read More

  • Global & Taiwan Cancer Therapeutics Market to 2031

    ... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More

  • Global & India Cancer Therapeutics Market to 2031

    ... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More

  • Global & China Cancer Therapeutics Market to 2031

    ... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More

  • Global & Italy Cancer Therapeutics Market to 2031

    ... cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was followed by colorectal cancer at 12.6% and lung cancer at 10.0%. That same year, cancer-related deaths reached around 190,000. Contributing to ... Read More

  • Global & Poland Cancer Therapeutics Market to 2031

    ... the Polish National Cancer Registry reported around 171,558 new cancer diagnoses and 93,652 cancer-related deaths. Additionally, data from the Spanish Network of Cancer Registries indicates that around 8,805 breast cancer deaths occurred in Poland that ... Read More

  • Global & Romania Cancer Therapeutics Market to 2031

    ... the Romanian Ministry of Health reporting approximately 100,000 new diagnoses each year. The increasing prevalence of risk factors such as tobacco use, unhealthy diets, and an aging population continues to drive cancer incidence rates, thereby ... Read More

  • Global & Philippines Cancer Therapeutics Market to 2031

    ... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More

  • Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2025-2033

    ... The market is propelled by the favorable government regulatory framework, widespread acceptance of the product, rapid growth of cultivation facilities and production capacity, increasing research and development (R&D) activities by key players, rising international investments ... Read More

  • HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030

    ... 2025 to 2030. Transplantation continues to be the preferred treatment option for many patients suffering from chronic dialysis-dependent end-stage renal disease, as well as those requiring heart, liver, or bone marrow transplants. Over the past ... Read More

  • Uterine Cancer Therapeutics and Diagnostics

    ... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion ... Read More

  • Patient Derived Xenograft / PDX Models

    ... reach US$1.0 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Mice PDX Models, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and ... Read More

  • Cancer / Tumor Profiling

    ... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the end ... Read More

  • Nano-Magnetic Devices

    ... CAGR of 5.4% over the analysis period 2024-2030. Sensors, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$12.8 Billion by the end of the analysis period. ... Read More

  • Colorectal Cancer Therapeutics

    ... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More

  • Cancer Gene Therapy

    ... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More

  • Cancer Diagnostics

    ... CAGR of 5.7% over the analysis period 2024-2030. Breast, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$56.4 Billion by the end of the analysis period. ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings